Overview

To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways

Status:
Completed

Trial end date:
2015-10-01

Target enrollment:

Participant gender:

Summary

The primary objectives of the study are to explore the effect of treatment with orally inhaled tiotropium + olodaterol fixed dose combination with and without exercise training, and tiotropium comparing to placebo, on top of behavioural modification in improving exercise capacity in patients with COPD

Phase:

Phase 3

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Olodaterol
Tiotropium Bromide